Pictet Asset Management Holding Sa Rhythm Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 259,346 shares of RYTM stock, worth $15.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
259,346
Previous 375,349
30.91%
Holding current value
$15.5 Million
Previous $21 Million
34.53%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding RYTM
# of Institutions
245Shares Held
62.9MCall Options Held
403KPut Options Held
62.8K-
Black Rock Inc. New York, NY6.74MShares$404 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$365 Million6.69% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$347 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$336 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$207 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.34B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...